Biomaterial and tissue-engineering strategies for the treatment of brain neurodegeneration
The incidence of neurodegenerative diseases is increasing due to changing age demographics and the incidence of sports-related traumatic brain injury is tending to increase over time. Currently approved medicines for neurodegenerative diseases only temporarily reduce the symptoms but cannot cure or...
Main Authors: | Bridget Martinez, Philip V Peplow |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
Series: | Neural Regeneration Research |
Subjects: | |
Online Access: | http://www.nrronline.org/article.asp?issn=1673-5374;year=2022;volume=17;issue=10;spage=2108;epage=2116;aulast=Martinez |
Similar Items
-
CD8+ T cells in brain injury and neurodegeneration
by: Zhaolong Zhang, et al.
Published: (2023-11-01) -
Editorial: The UN international day of families: neurodegeneration as a result of genetic inheritance
by: Iliyana Hristova Pacheva, et al.
Published: (2023-10-01) -
Adamantanes for the treatment of neurodegenerative diseases in the presence of SARS-CoV-2
by: Roger F. Butterworth
Published: (2023-03-01) -
Pathological correlations between traumatic brain injury and chronic neurodegenerative diseases
by: Marcela Cruz-Haces, et al.
Published: (2017-07-01) -
MicroRNA in Brain pathology: Neurodegeneration the Other Side of the Brain Cancer
by: Jakub Godlewski, et al.
Published: (2019-02-01)